Evidence map›Paper›PMID 37241950›Full record

ReviewMolecules (Basel, Switzerland)2023

Synthetic Routes to Approved Drugs Containing a Spirocycle.

Nazar Moshnenko, Alexander Kazantsev, Evgeny Chupakhin, Olga Bakulina, Dmitry Dar'in

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Enantioselective Preparation of (Molecules (Basel, Switzerland) · 2025
    Review
  6. Enzymatic Stereodivergent Synthesis of Azaspiro[2.y]alkanes.Journal of the American Chemical Society · 2025
    Article
  7. A Review of Approaches Developed for Spiroether Synthesis.Topics in current chemistry (Cham) · 2025
    Review
  8. Enantioselective Spirocyclization of Pd-Enolates and Isocyanates.Angewandte Chemie (International ed. in English) · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nazar MoshnenkoInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Alexander KazantsevInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0002-0050-7288
Evgeny ChupakhinInstitute of Living Systems, Immanuel Kant Baltic Federal University, 236016 Kaliningrad, Russia.ORCID 0000-0001-5284-4748
Olga BakulinaInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Dmitry Dar'inInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0002-0413-7413

Funding

Russian Foundation for Basic Research 21-53-12001
6 · The paper itself

Abstract

The use of spirocycles in drug discovery and medicinal chemistry has been booming in the last two decades. This has clearly translated into the landscape of approved drugs. Among two dozen clinically used medicines containing a spirocycle, 50% have been approved in the 21st century. The present review focuses on the notable synthetic routes to such drugs invented in industry and academia, and is intended to serve as a useful reference source of synthetic as well as general drug information for researchers engaging in the design of new spirocyclic scaffolds for medicinal use or embarking upon analog syntheses inspired by the existing approved drugs.

Indexed as

Chemistry, PharmaceuticalDrug Discoveryapproved drugscyclodehydrationhigh-Fsp3intramolecular alkylationintramolecular claisen condensationketalizationspirocyclesspirocyclizationsthree-dimensional

Identifiers

PMID37241950
PMCPMC10223694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.